Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Change in Receivables (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Change in Receivables readings, the most recent being -$141.0 million for Q1 2026.

  • On a quarterly basis, Change in Receivables fell 74.07% to -$141.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $156.0 million, a 35.27% decrease, with the full-year FY2025 number at $216.0 million, up 37.58% from a year prior.
  • Change in Receivables hit -$141.0 million in Q1 2026 for GE HealthCare Technologies, down from $210.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $258.0 million in Q4 2024 to a low of -$165.0 million in Q1 2024.
  • Median Change in Receivables over the past 5 years was $25.0 million (2024), compared with a mean of $37.4 million.
  • Biggest five-year swings in Change in Receivables: plummeted 850.0% in 2024 and later soared 664.0% in 2025.
  • GE HealthCare Technologies' Change in Receivables stood at $124.0 million in 2022, then decreased by 26.61% to $91.0 million in 2023, then soared by 183.52% to $258.0 million in 2024, then fell by 18.6% to $210.0 million in 2025, then tumbled by 167.14% to -$141.0 million in 2026.
  • The last three reported values for Change in Receivables were -$141.0 million (Q1 2026), $210.0 million (Q4 2025), and $191.0 million (Q3 2025) per Business Quant data.